We found that CHST2 and the well-known target genes of the proposed drugs, HRH1, and EGFR/ERBB2, were co-expressed in the GBM tumours as shown in iNetModels (Figures S6 and S7). This evidence concerns the gene ERBB2 and neoplasm.